Results 121 to 130 of about 5,167 (169)

Prevalence of JC polyomavirus among rheumatoid arthritis and systemic lupus erythematosus patients and its correlation with vitamin D levels. [PDF]

Iran J Microbiol
Irani Mokhtari G, Azaran A, Rajahi E, Hesam S, Dehghani Ghahfarokhi A, Makvandi M.   +5 more
europepmc   +1 more source

Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report. [PDF]

BMC Urol
Lv Y, Liu X.
europepmc   +1 more source

Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. [PDF]

J Infect Dis
Jost S, Ahn J, Chen S, Yoder T, Gikundiro KE, Lee E, Gressens SB, Kroll K, Craemer M, Kaynor GC, Lifton M, Tan CS.   +11 more
europepmc   +1 more source

Evaluating Neural Network Performance in Predicting Disease Status and Tissue Source of JC Polyomavirus from Patient Isolates Based on the Hypervariable Region of the Viral Genome. [PDF]

Viruses
Pike AMC, Amal S, Maginnis MS, Wilczek MP.   +3 more
europepmc   +1 more source

Development of intranuclear inclusions of human polyomavirus JC.

Uirusu, 2006
openaire   +2 more sources

[Progressive multifocal leukoencephalopathy caused by JC polyomavirus].

Medicina, 2003
Marcelo, Corti, María Florencia, Villafañe, Claudio, Yampolsky   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

JC Polyomavirus Infection Potentiated by Biologics

Infectious Disease Clinics of North America, 2020
The risk of JC polyomavirus encephalopathy varies among biologic classes and among agents within the same class. Of currently used biologics, the highest risk is seen with natalizumab followed by rituximab. Multiple other agents have also been implicated.
Ashrit, Multani, Dora Y, Ho
openaire   +2 more sources